A Study of BW-20507 in Chinese Healthy Subjects and Subjects With Chronic Hepatitis B
Clinical trial NCT07595159 · COMPLETED
Trial details
- NCT number
- NCT07595159
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2025-11-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.